Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Symrise AG    SY1   DE000SYM9999

SYMRISE AG

(SY1)
  Report
Real-time Estimate Quote. Real-time Estimate TRADEGATE AG - 09/22 12:55:07 pm
118.1750 EUR   +0.02%
09/11SYMRISE : advances sustainable packaging
AQ
09/09NEW CLINICAL DATA SUGGESTS : Symrise anti-dandruff active promotes healthy scalp microbiome
AQ
09/07SYMRISE AG : UBS reaffirms its Neutral rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Symrise : Press Release Interim Group Report January-June 2020

share with twitter share with LinkedIn share with facebook
08/07/2020 | 03:44am EDT

Press release

-

Holzminden, 6 August 2020

Interim Group Report: January - June 2020

Symrise achieves highly profitable growth in a challenging market environment

  • Year-on-yearsales increase of 7.6 % during global coronavirus pandemic
  • Organic sales growth of 3.4 % in the first six months and 4.6 % in the second quarter
  • EBITDA margin improved to an outstanding 21.6 %
  • 2020 outlook for the EBITDA margin raised to a range of 21 to 22 %
  • Sales goal for 2020 and medium-term goals for 2025 confirmed

Symrise very successfully continued its profitable growth course in the first half of 2020 also during the global coronavirus pandemic. The Group increased its sales by 7.6 % to € 1,821 million in an economically challenging market environment. In organic terms - i.e. excluding the portfolio effect of the ADF/IDF acquisition and exchange rate effects - sales were up by 3.4 %. All segments contributed to this positive development. Earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 11.9 % to € 393 million as compared to the previous year's level normalized for acquisition and integration costs for ADF/IDF (H1 2019: € 351 million). Profitability developed particularly well: The EBITDA margin rose to 21.6 % and lies thus significantly higher than the profitability target for 2020. The net income for the reporting period increased to € 169 million. Against the backdrop of the strong business performance and profitability trend in the first half of the year, Symrise is raising its full-year EBITDA margin guidance from 20 % to a range of 21 to 22 %.

"In the second quarter the coronavirus pandemic began to significantly impact the global economy and above all many people's everyday lives. Even in this historically exceptional situation, Symrise has done an excellent job of staying on course. Thanks to our global presence, diversified portfolio and broad customer base, our feet rest very firmly on the ground. We remained fully operational in the second quarter and were able to supply our customers in the usual reliable manner," said Dr Heinz-Jürgen Ber- tram, CEO of Symrise AG. "Of course, it is hard to predict the course of the coronavirus pandemic. However, after our performance in the first half of the year, we are looking ahead to the second half with confidence. For the full fiscal year 2020 we again want to grow faster than the market and expect that we will achieve increased profitability overall. We are therefore raising our guidance for the EBITDA margin to a range of 21 to 22 %."

With coronavirus pandemic ongoing, continued growth in all segments

The Symrise Group achieved sales growth of 7.6 % in the first half of 2020 to € 1,821 million (H1 2019:

  • 1,692 million). The acquisition of ADF/IDF had a positive impact of € 106 million on sales perfor- mance. In organic terms, sales increased by 3.4 %. Amid the coronavirus pandemic, changes in con- sumer behavior were seen for the first time in the Scent & Care and Flavor segments in the second quarter. This resulted in both positive and negative effects on demand in individual business units. With

1

its broad range of product solutions for foods, personal care and hygiene, Symrise serves the needs of everyday life, especially in these difficult times.

The Scent & Care segment

Scent & Care achieved solid organic growth of 2.6 % in the first half of 2020. Taking currency translation effects into account, sales in the first six months in the reporting currency amounted to € 711 million and were therefore almost unchanged as compared to the same period of the previous year (H1 2019: € 712 million).

Strong demand in the Fragrance division drove sales in the Consumer Fragrances and Oral Care business units, which recorded high organic growth in the single and double-digit range respectively. The Fine Fragrances business unit, at the same time noticed the effects of the coronavirus pandemic clearly. The worldwide reduction in travel activity and closed stores due to lockdowns had a negative impact on the demand for luxury items. Overall, the Fragrance division achieved solid organic growth in the single- digit percentage range with increases in all regions.

Sales in the Aroma Molecules division in the first six months of 2020 ranged slightly below the high level of the previous year, mainly due to weaker demand for fragrances. On the other hand, positive momentum came from the Menthols business unit, which achieved organic growth in the double-digit percentage range. The EAME, North and Latin America regions achieved the strongest gains.

Sales in the Cosmetic Ingredients division were affected by weaker demand for sun protection products, attributable mainly to the reduction in travel due to the coronavirus pandemic. The other business units showed good organic growth in the single and double-digit percentage range. Key growth markets were Brazil, China and Korea in the Latin America and Asia/Pacific regions .

The Scent & Care segment improved EBITDA to € 146 million (H1 2019: € 140 million). The EBITDA

margin for the period under review increased to 20.6 % (H1 2019: 19.7 %).

The Flavor segment

Flavor achieved organic growth of 0.6 % in the period under review. Taking currency translation effects into account, segment sales in the reporting currency amounted to € 636 million (H1 2019: € 637 mil- lion). Against the backdrop of the coronavirus pandemic, the trend toward cooking and eating at home led to a strong demand for products from the Savory business unit and product solutions for baked goods and cereals. At the same time, reduced out-of-home eating and drinking led to a lower demand for beverage products and sweets.

In the EAME region, the Flavor segment suffered from significantly reduced demand for beverage products and sweets, while the Savory business unit recorded a high single-digit growth rate. Germany and the Gulf region achieved the strongest gains. Overall, sales in the EAME region remained slightly below the figure for the first half of 2019.

Organic sales in North America were roughly on par with the same period of the previous year. While Savory product solutions enjoyed great demand, beverage products and sweets sold less.

2

The Asia/Pacific region reported organic growth in the single-digit percentage range, driven primarily by very strong demand for products from the Savory business unit, which showed organic growth in the double-digit percentage range. The largest increases came from the national markets of Indonesia, Thailand, Vietnam and Singapore.

The Latin America region achieved the strongest growth in the segment in the first half of 2020 and was largely unaffected by the coronavirus pandemic. All business units realized high organic growth in the single or double-digit percentage range. Strong gains were posted especially in the national markets of Brazil, Uruguay and Mexico.

The EBITDA of the Flavor segment was up 2.2 % to € 147 million (H1 2019: € 144 million). The EBITDA margin improved from 22.6 % in the first half of 2019 to a very strong 23.2 %, mainly due to tight control on costs and proportionally lower raw materials costs.

The Nutrition segment

Nutrition achieved strong organic growth of 10.5 %. Accounting for portfolio and currency translation effects, sales in the reporting currency amounted to € 474 million and were 38.1 % above the previous year's level (H1 2019: € 343 million). ADF/IDF contributed sales of € 106 million.

The Pet Food business unit proved to be the growth driver of the segment, achieving high organic growth in the double-digit percentage range in all regions. Sales developed particularly dynamically in the USA, Mexico, Brazil and Russia.

In the Food business unit, the Asia/Pacific region stood out with double-digit growth, especially in China, India and Taiwan. In the EAME region, sales matched the previous year's level, while North and Latin America dropped slightly below the last year.

Strong impetus came from the Aqua business unit, which achieved good growth especially in the EAME and Asia/Pacific regions.

Probi reported growth in the single-digit percentage range during the reporting period, primarily driven by the North America and Asia/Pacific regions.

The Nutrition segment generated an EBITDA of € 100 million in the reporting period (H1 2019 EBITDA(N): € 67 million). The EBITDA margin in the segment increased by 1.5 percentage points to

21.0 % (EBITDA(N) margin H1 2019: 19.5 %). The improved profitability is mainly due to the good per- formance of Pet Food and the inclusion of ADF/IDF.

Operating result

Also within the challenging environment dominated by the coronavirus pandemic, Symrise was highly profitable in the first half of 2020. The Group recorded EBITDA of € 393 million. This represents an increase of 11.9 % over the same period a year earlier. This trend relates primarily to profitable sales growth and the inclusion of ADF/IDF. The EBITDA margin improved by 0.8 percentage points to 21.6 % (EBITDA(N) H1 2019: 20.8 %).

3

Net income for the period and earnings per share

Net income for the reporting period amounted to € 169 million, which was € 16 million above the normal- ized figure from the previous year of € 153 million. Basic earnings per share increased 10 % to € 1.25 after € 1.14 (normalized) in the first half of the previous year.

Cash flow from operating activities

The cash flow from operating activities for the first half of 2020 of € 219 million was € 78 million higher than the previous year's level of € 141 million. The increase is mainly due to the improved operating result and the inclusion of ADF/IDF.

Financial position

Net debt increased by € 28 million to € 1,645 million compared to the reporting date of 31 December 2019. The ratio of net debt including lease liabilities to EBITDA(N) thus amounted to 2.2. Including pension obligations and lease liabilities, net debt equaled € 2,261 million, which corresponds to a ratio of net debt to EBITDA(N) of 3.0.

Symrise remains confident about the current fiscal year and raises EBITDA margin target

With its global presence, a steadily growing and diversified portfolio and broad customer base, Symrise considers itself to be robust and securely positioned even in the current challenging market environ- ment. The Group is fully operational worldwide and is able to supply customers sustainably.

Even though the effects of the pandemic can only be estimated to a limited extent, the Group remains confident that it will again grow faster than the relevant market over the remainder of the year. The market growth is estimated to be around 3 to 4 %. Symrise considers itself to be well positioned to achieve the sales targets confirmed at the beginning of 2020.

Based on the strong business performance and profitability trend in the first half of the year, the Group is raising its original target of over 20 % for the EBITDA margin. For the 2020 fiscal year, Symrise now expects an EBITDA margin in the range of 21 to 22 %.

The medium-term targets also remain in effect. The company aims to increase its annual sales to € 5.5 to € 6.0 billion by the end of the 2025 fiscal year. Symrise wants to achieve this with an annual organic growth of 5 to 7 % (CAGR) as well as additional targeted acquisitions. In the medium term, profitability should remain within a target corridor of 20 to 23 %.

4

About Symrise:

Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food.

Its sales of approximately € 3.4 billion in the 2019 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America.

Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. Symrise - always inspiring more …

www.symrise.com

Media contact:

Investor contact:

Bernhard Kott

TobiasErfurth

Tel.: +49 (0)5531 90-1721

Tel.: +49 (0)5531 90-1879

Email: bernhard.kott@symrise.com

Email: tobias.erfurth@symrise.com

Social media:

linkedin.com/company/symrise

twitter.com/symriseag

youtube.com/agsymrise

xing.com/companies/symrise

instagram.com/symriseag

Financial calendar 2020

29 October

Interim Group Report January-September 2020 (trading update)

5

6

Disclaimer

Symrise AG published this content on 06 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 August 2020 07:43:14 UTC

share with twitter share with LinkedIn share with facebook
All news about SYMRISE AG
09/11SYMRISE : advances sustainable packaging
AQ
09/09NEW CLINICAL DATA SUGGESTS : Symrise anti-dandruff active promotes healthy scalp..
AQ
09/07SYMRISE AG : UBS reaffirms its Neutral rating
MD
09/04SYMRISE AG : Baader Bank reiterates its Buy rating
MD
09/01SYMRISE AG : UBS sticks Neutral
MD
08/31SYMRISE : Atos and Symrise extend contract to advance digitalization with innova..
AQ
08/27PROBI : New clinical results on stress from Probi and their probiotic strain L. ..
AQ
08/26SYMRISE : presents innovative active for itchy scalp and healthy hair
AQ
08/26SYMRISE AG : Barclays gives a Neutral rating
MD
08/21SYMRISE : Study reveals importance of naturalness to food and beverage consumers..
AQ
More news
Financials
Sales 2020 3 619 M 4 251 M 4 251 M
Net income 2020 345 M 405 M 405 M
Net Debt 2020 1 345 M 1 579 M 1 579 M
P/E ratio 2020 47,9x
Yield 2020 0,88%
Capitalization 16 001 M 18 776 M 18 794 M
EV / Sales 2020 4,79x
EV / Sales 2021 4,50x
Nbr of Employees 10 413
Free-Float 91,2%
Chart SYMRISE AG
Duration : Period :
Symrise AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYMRISE AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 105,57 €
Last Close Price 118,15 €
Spread / Highest target 12,6%
Spread / Average Target -10,7%
Spread / Lowest Target -31,4%
EPS Revisions
Managers
NameTitle
Heinz-Jürgen Bertram Chief Executive Officer
Michael König Chairman-Supervisory Board
Olaf Klinger Chief Financial Officer
Horst-Otto Gerberding Member-Supervisory Board
Peter Winkelmann Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SYMRISE AG25.96%18 776
ECOLAB INC.2.84%56 640
GIVAUDAN SA33.62%40 777
SIKA AG19.38%33 571
EMS-CHEMIE HOLDING AG32.44%21 510
UMICORE-10.72%10 926